influenza
virus
belong
famili
orthomyxovirida
import
caus
acut
respiratori
infect
caus
annual
epidem
human
popul
although
case
infect
selflimit
restrict
upper
respiratori
tract
certain
patient
group
elderli
risk
develop
complic
lead
high
morbid
mortal
vaccin
circul
influenza
strain
readili
avail
trival
quadrival
design
protect
influenza
virus
subtyp
one
lineag
influenza
b
viru
sever
differ
vaccin
formul
avail
trival
quadrival
inactiv
viru
vaccin
tiv
qiv
either
whole
viru
split
viru
subunit
vaccin
live
attenu
influenza
viru
vaccin
laiv
vaccin
produc
embryon
chicken
egg
vaccin
produc
mammalian
insect
cell
also
avail
inactiv
vaccin
administ
intramuscularli
im
sometim
intraderm
predominantli
aim
induct
serum
antibodi
respons
viral
hemagglutinin
ha
neuraminidas
na
lesser
extent
protect
diseas
mainli
mediat
viru
neutral
antibodi
ha
naspecif
antibodi
also
contribut
protect
current
licens
laiv
administ
local
via
nasal
spray
virus
attenu
choic
viral
backbon
coldadapt
virus
therefor
temperaturesensit
replic
local
administr
mucosa
addit
serum
antibodi
immun
laiv
also
induc
mucos
antibodi
cytotox
tlymphocyt
ctl
although
current
avail
influenza
vaccin
effect
reduc
morbid
mortal
caus
season
influenza
virus
sever
limit
mainli
continu
antigen
drift
season
influenza
virus
complic
product
effect
vaccin
vaccin
strain
need
updat
almost
annual
order
achiev
good
antigen
match
epidem
viru
strain
vaccin
strain
antigen
match
circul
strain
vaccin
efficaci
reduc
consider
case
influenza
furthermor
season
influenza
vaccin
afford
littl
protect
antigen
distinct
pandem
influenza
virus
often
altern
subtyp
antibodi
virtual
absent
human
popul
last
decad
zoonot
transmiss
highli
pathogen
avian
influenza
virus
particular
subtyp
report
regularli
capac
avian
virus
subtyp
includ
infect
human
fuell
fear
pandem
outbreak
caus
virus
vaccin
produc
accord
procedur
use
product
season
influenza
vaccin
prove
poorli
immunogen
case
use
adjuv
requir
effici
induct
protect
antibodi
furthermor
pandem
caus
swineorigin
influenza
virus
subtyp
taught
import
lesson
product
tailor
made
pandem
influenza
vaccin
prove
timeconsum
process
mani
countri
vaccin
becam
avail
peak
limit
current
avail
vaccin
product
technolog
vaccin
underscor
press
need
gamechang
vaccin
addit
improv
immunogen
high
risk
group
novel
vaccin
requir
induc
longlast
immun
wide
rang
influenza
virus
produc
rapidli
face
pandem
outbreak
improv
immunogen
influenza
vaccin
specif
elderli
highdos
vaccin
adjuv
vaccin
develop
latter
use
europ
us
sinc
respect
use
viral
vector
influenza
vaccin
product
may
solut
problem
discuss
review
discuss
variou
viral
vector
test
candid
influenza
vaccin
anim
model
clinic
trial
viral
vector
consid
live
vaccin
replic
attenu
even
defici
therefor
vectorbas
vaccin
consid
safe
gener
even
safe
use
immunocompromis
despit
attenu
phenotyp
viral
vector
immunogen
induc
virusspecif
antibodi
cell
respons
system
parenter
administr
addit
viral
vector
easili
propag
high
viru
titer
rel
easi
insert
gene
encod
antigen
choic
vector
viral
vector
technolog
also
allow
product
modifi
influenza
viral
antigen
vivo
modif
improv
immunogen
influenza
viral
protein
alter
specif
immun
respons
review
discuss
report
vector
influenza
vaccin
discuss
advantag
disadvantag
mva
attenu
vv
strain
deriv
chorioallantoi
vaccinia
viru
ankara
serial
passag
chicken
embryo
result
major
delet
viral
genom
influenc
mani
virul
immun
evas
consequ
mva
replic
highli
restrict
avian
cell
mva
unabl
produc
infecti
progeni
mammalian
cell
sinc
mva
replicationdefici
mammalian
cell
therefor
lowli
reactogen
human
attract
vector
vaccin
purpos
demonstr
field
trial
mva
success
use
safe
smallpox
vaccin
individu
absenc
seriou
advers
howev
use
mva
vaccin
vector
multipl
altern
advantag
notabl
mva
safeti
confirm
variou
vivo
model
includ
avian
speci
mammal
lead
classif
mva
biosafeti
level
pathogen
addit
advantag
mva
vaccin
vector
includ
easi
insert
antigen
interest
viral
genom
transient
express
heterolog
antigen
vivo
induct
humor
cellular
respons
anim
model
human
final
interest
characterist
mva
compar
vv
mva
lost
capac
evad
host
innat
immun
consequ
vaccin
mva
intrins
immunostimulatori
activ
potenti
compar
adjuv
use
combin
vaccin
lead
rapid
influx
variou
type
immun
although
potenti
neg
effect
preexist
vector
immun
immunogen
alway
concern
use
vector
vaccin
seem
major
problem
mvabas
vaccin
shown
human
second
booster
vaccin
mva
express
influenza
viru
ha
still
result
potent
antibodi
respons
protein
interest
similar
observ
made
studi
mva
express
protein
review
indic
recombin
mva
remain
immunogen
despit
vector
immun
mva
hold
great
promis
vaccin
vector
initi
shown
promis
influenza
vaccin
sutter
et
vaccin
engin
express
ha
nucleoprotein
np
gene
influenza
viru
addit
recombin
mva
express
protein
variou
influenza
strain
gener
test
anim
model
induc
steril
immun
influenza
virus
ha
surfac
antigen
choic
sinc
effici
stimul
bcell
respons
product
viru
neutral
antibodi
vn
vivo
therefor
mva
vector
vaccin
express
ha
variou
subtyp
construct
test
anim
model
note
howev
antibodi
direct
ha
strainspecif
display
poor
crossreact
altern
subtyp
even
ha
molecul
virus
subtyp
therefor
mvaha
vaccin
often
offer
protect
infect
homolog
influenza
viru
poorli
infect
heterolog
virus
recombin
mva
express
ha
gene
influenza
viru
test
immunogen
mice
ferret
macaqu
differ
studi
mice
could
fulli
protect
diseas
challeng
infect
homolog
viru
protect
correl
induct
vn
antibodi
tcell
addit
intrasubtyp
crossimmun
observ
extent
could
also
protect
mice
infect
variou
swine
influenza
immun
ferret
similar
recombin
mva
induc
robust
antibodi
respons
partial
protect
challeng
infect
antigen
close
relat
viru
macaqu
also
fulli
protect
viru
infect
immun
mvabas
taken
togeth
data
indic
mvabas
vaccin
abl
induc
protect
immun
viru
caus
influenza
pandem
extent
crossprotect
unrel
virus
limit
highli
pathogen
avian
influenza
virus
subtyp
caus
endem
outbreak
poultri
howev
sinc
zoonot
transmiss
variou
virus
caus
mani
case
human
almost
fatal
outcom
zoonot
transmiss
virus
continu
circul
wild
domest
bird
fact
amino
acid
substitut
necessari
confer
transmiss
underscor
pandem
potenti
virus
circul
virus
belong
antigen
distinct
clade
complic
vaccin
develop
necessit
select
variou
prototyp
vaccin
strain
recombin
mva
vaccin
express
ha
gene
deriv
variou
strain
construct
test
protect
efficaci
virus
belong
differ
clade
variou
anim
model
vaccin
mva
express
ha
gene
influenza
viru
clade
complet
protect
mice
chicken
infect
homolog
viru
also
offer
mice
protect
infect
influenza
virus
clade
clade
regard
induc
antibodi
crossreact
ha
virus
belong
heterolog
clade
virus
perform
superior
compar
mva
express
ha
influenza
virus
clade
clade
clade
clade
clade
final
immun
protect
macaqu
challeng
infect
homolog
viru
clade
viru
favor
outcom
justifi
test
phase
clinic
trial
show
vaccin
candid
immunogen
man
vn
antibodi
induc
homolog
strain
crossreact
heterolog
virus
even
newli
emerg
avian
influenza
vaccin
well
toler
seriou
advers
event
observ
collect
data
show
mvabas
vaccin
safe
abl
induc
crossclad
specif
antibodi
level
consid
protect
addit
mva
express
ha
gene
deriv
influenza
virus
test
anim
model
mva
vaccin
express
ha
gene
equin
influenza
viru
test
poni
shown
induc
antibodi
tcell
respons
afford
protect
diseas
caus
challeng
infect
homolog
recent
avian
influenza
virus
subtyp
caus
frequent
infect
human
especi
southeast
china
often
fatal
outcom
candid
mvabas
vaccin
express
ha
gene
one
virus
construct
test
ferret
shown
immun
induc
vn
antibodi
offer
partial
protect
challeng
infect
closelyrel
wherea
ha
regard
antigen
choic
induct
vn
antibodi
respons
conserv
intern
np
matrix
protein
often
regard
antigen
choic
induct
tcell
respons
particular
ctl
respons
gener
habas
vaccin
induc
rel
narrow
antibodi
respons
afford
littl
crossprotect
immun
virus
subtyp
contrast
use
conserv
influenza
viru
protein
vaccin
may
lead
induct
tcell
direct
epitop
share
influenza
virus
variou
subtyp
may
confer
broader
protect
induct
broadlyprotect
immun
mvana
mvanp
vaccin
construct
test
anim
model
note
vaccin
aim
induct
cell
immun
exclus
afford
steril
immun
initi
infect
degre
viru
replic
prevent
howev
ctl
recogn
elimin
virusinfect
cell
therebi
contribut
viral
clearanc
recoveri
hessel
et
al
construct
recombin
mva
express
np
gene
viru
mvanp
immun
mice
vaccin
candid
protect
anim
infect
homolog
viru
also
infect
virus
howev
similar
mvanp
construct
fail
induc
protect
immun
use
mva
express
gene
viru
also
fail
induc
protect
immun
mva
express
np
gene
equin
viru
mvanp
offer
poni
partial
protect
infect
initi
prime
dna
vaccin
express
mva
express
na
gene
viru
afford
partial
protect
challeng
order
elicit
protect
antibodi
tcell
respons
simultan
mva
express
ha
np
gene
construct
mous
studi
use
vaccin
induc
virusspecif
antibodi
tcell
respons
fulli
protect
mice
infect
homolog
viru
partial
protect
infect
unrel
similarli
construct
contain
ha
gene
np
gene
viru
mice
vaccin
afford
complet
protect
infect
homolog
strain
partial
protect
infect
viru
similar
construct
test
macaqu
full
protect
observ
infect
viru
ha
gene
replac
viru
macaqu
partial
protect
infect
mva
simultan
express
ha
na
gene
viru
gene
test
mice
shown
afford
protect
infect
mva
vaccin
design
induc
tcell
respons
express
np
gene
viru
extens
test
first
anim
model
clinic
trial
immun
mice
afford
protect
develop
sever
diseas
infect
influenza
virus
infect
mouseadapt
viru
studi
recombin
mva
given
adjunct
recombin
adenoviru
express
gene
vaccin
strategi
chicken
protect
infect
viru
thu
recombin
mva
express
conserv
np
gene
simultan
broad
immun
respons
induc
protect
variou
subtyp
influenza
vaccin
regimen
prove
immunogen
pig
protect
potenti
test
vaccin
subsequ
test
phase
clinic
trial
shown
induc
virusspecif
tcell
human
protect
experiment
challeng
infect
furthermor
vaccin
regimen
shown
safe
immunogen
could
coadminist
variabl
natur
influenza
virus
extens
antigen
variat
display
avail
socal
univers
vaccin
highli
desir
mva
discuss
induc
crossreact
immun
respons
particular
base
induct
virusspecif
cell
commonli
unmodifi
antigen
use
current
variou
modif
viral
protein
test
order
design
vaccin
induc
broader
immun
modifi
influenza
viral
antigen
express
recombin
viral
vector
includ
mva
test
anim
model
recent
kamlangde
et
al
gener
construct
mva
express
comput
gener
mosaic
gene
reflect
gene
sequenc
viru
isol
vaccin
capabl
induc
antibodi
react
virus
clade
crossreact
virus
ha
subtyp
interestingli
immun
mice
protect
infect
variou
virus
also
infect
viru
subtyp
protect
challeng
infect
could
anoth
vaccin
approach
interest
design
vaccin
induc
broadlyreact
vn
antibodi
conserv
stalk
region
ha
singl
studi
perform
vaccin
challeng
experi
mva
express
hastalk
either
alon
combin
use
alon
combin
mva
express
repeat
afford
protect
immun
howev
without
mva
express
construct
combin
mva
express
np
gene
mvanp
mice
protect
infect
coadministr
np
express
vaccin
seem
essenti
achiev
crossprotect
studi
correspond
induct
broadlyreact
virusspecif
tcell
thu
shown
influenza
viru
antigen
modifi
optim
induct
crossreact
immun
respons
modifi
viral
antigen
readili
express
recombin
mva
vector
thu
mva
provid
ideal
platform
express
modifi
influenza
viral
protein
smartli
design
induct
broadli
protect
immun
next
mva
attenu
poxvirus
use
viral
vector
develop
candid
influenza
vaccin
immun
chicken
recombin
nyvac
vv
strain
highli
attenu
delet
open
read
frame
viral
express
ha
gene
avian
viru
afford
protect
infect
heterolog
recombin
raccoonpox
rcn
virus
express
ha
na
np
gene
influenza
viru
construct
evalu
protect
capac
mice
interestingli
protect
challeng
infect
could
demonstr
depend
rout
administr
intraderm
immun
rcnha
afford
protect
protect
also
observ
rcnna
intranas
canarypox
cnpv
hostrestrict
member
poxviru
famili
unabl
produc
infecti
progeni
viru
mammalian
cell
make
potenti
safe
viral
vector
human
use
present
recombin
cnpv
use
influenza
vector
vaccin
vaccin
hors
equin
influenza
subtyp
recombin
cnpv
vaccin
express
ha
gene
variou
strain
immunogen
hors
protect
infect
viru
furthermor
matern
antibodi
induc
cnpvha
passiv
transfer
foal
vaccin
pregnant
addit
cnpv
also
use
vaccin
vector
protect
pig
cat
avian
influenza
viru
subtyp
pig
vaccin
cnpvha
prove
protect
infect
unrel
viru
cat
vaccin
afford
protect
infect
variou
fowlpox
viru
fpv
caus
agent
econom
import
diseas
chicken
howev
sever
attenu
fpv
vector
vaccin
express
influenza
viru
antigen
current
licens
influenza
vaccin
use
poultri
initi
studi
perform
show
fpvha
vaccin
could
protect
chicken
turkey
experiment
challeng
compar
mva
recent
shown
fpv
vector
effici
induc
b
tcell
respons
howev
also
shown
preexist
immun
fpv
influenza
antigen
could
pose
potenti
problem
use
fpvbase
influenza
experiment
fpvbase
vaccin
express
ha
gene
viru
extens
test
chicken
shown
offer
protect
infect
homolog
viru
also
virus
variou
vaccin
construct
test
chicken
duck
prove
afford
protect
infect
homolog
heterolog
furthermor
recombin
fpv
vaccin
gener
express
ha
gene
virus
fail
protect
chicken
infect
vaccin
recombin
fpv
express
homolog
ha
gene
afford
full
similar
result
obtain
recombin
fpv
vaccin
express
ha
gene
avian
influenza
interestingli
coexpress
gene
improv
immunogen
fpvha
vaccin
chicken
recombin
fpv
vaccin
express
influenza
viru
np
na
gene
test
well
recombin
fpv
express
np
fail
protect
chicken
infect
howev
fpvbase
vaccin
express
ha
np
gene
simultan
protect
chicken
complet
homolog
challeng
notabl
recombin
fpv
express
ha
na
gene
viru
protect
chicken
complet
infect
homolog
viru
also
infect
viru
anoth
subtyp
name
although
fpv
vector
vaccin
express
influenza
viral
antigen
rare
use
nonavian
speci
fpvha
capabl
induc
antibodi
respons
cat
afford
protect
pig
challeng
lowpathogen
influenza
alphavirus
singlestrand
rna
virus
posit
sens
genom
togavirida
famili
sever
alphavirus
develop
vaccin
vector
includ
semliki
forest
viru
sfv
sindbi
viru
sin
venezuelan
equin
enceph
vee
vector
often
replic
defici
replicon
encod
viral
structur
protein
region
genom
replac
transgen
interest
viral
rna
selfrepl
capabl
transgen
express
high
ad
advantag
use
alphaviru
replicon
preexist
immun
vector
pose
problem
multipl
sequenti
vaccin
furthermor
vee
appeal
vaccin
vector
previous
shown
vee
mainli
target
antigenpres
cell
lymphoid
tissu
therefor
prime
rapid
robust
immun
sin
sfv
vee
test
influenza
vaccin
vector
tabl
sfv
vaccin
express
ha
np
gene
could
protect
mice
infect
viru
held
true
sin
replicon
express
either
ha
gene
immunodomin
tcell
np
vee
extens
evalu
influenza
vaccin
vector
vaccin
protect
mice
infect
homolog
even
age
immun
chicken
vee
express
ha
gene
viru
also
afford
full
protect
final
vaccin
pig
studi
use
differ
vee
construct
express
ha
gene
subtyp
np
gene
swine
influenza
viru
case
antibodi
induc
vaccin
pig
could
least
partial
protect
infect
homolog
heterosubtyp
immun
could
induc
pig
vaccin
veenp
howev
veebas
vaccin
perform
poorli
presenc
matern
veebas
candid
vaccin
cytomegaloviru
cmv
test
clinic
trial
shown
immunogen
well
toler
safe
clinic
trial
alphavirusesbas
vector
influenza
vaccin
yet
conduct
howev
sinc
replicon
potenti
efficaci
even
face
preexist
immun
safe
hold
promis
influenza
vector
vaccin
sever
recombin
herp
virus
test
anim
model
candid
influenza
vaccin
tabl
duck
enter
viru
dev
alphaherpesviru
caus
agent
duck
plagu
caus
fatal
infect
mani
speci
waterfowl
howev
delet
glycoprotein
c
gc
lead
attenu
dev
may
exploit
develop
vector
vaccin
construct
first
devbas
candid
influenza
vaccin
initi
describ
subsequ
shown
dev
encod
differ
virus
could
protect
chicken
duck
lethal
infect
capabl
induc
humor
cellular
immun
infecti
laryngotrach
viru
iltv
anoth
alphaherpesviru
caus
diseas
mainli
poultri
test
influenza
vaccin
poultri
attenu
strain
iltv
express
ha
gene
obtain
variou
influenza
viru
strain
gener
shown
offer
protect
howev
iltv
attenu
suffici
pathogen
caus
vector
still
observ
singl
iltv
vaccin
express
na
gene
also
gener
poorli
immunogen
coexpress
ha
gene
alway
requir
obtain
protect
anoth
alphaherpesviru
poultri
turkey
herpesviru
hvt
also
extens
studi
influenza
vaccin
vector
chicken
hvt
encod
ha
gene
viru
afford
protect
infect
variou
similarli
recombin
vaccin
protect
chicken
infect
homolog
sinc
chicken
often
vaccin
young
age
day
birth
matern
antibodi
vector
protein
encod
transgen
could
influenc
vaccin
efficaci
interestingli
hvt
shown
immunogen
even
presenc
matern
marek
diseas
viru
mdv
alphaherpesviru
close
relat
hvt
shown
effect
vaccin
vector
viru
even
perform
better
hvt
sidebysid
comparison
pseudorabiesviru
prv
alphaherpesviru
pig
attenu
strain
prv
gener
use
control
aujeszki
diseas
attenu
prv
express
foreign
antigen
gener
attract
bival
vaccin
pig
use
influenza
vaccin
partial
protect
pig
viru
infect
recombin
prv
express
na
gene
deriv
swine
influenza
viru
protect
pig
limit
recombin
prv
express
ha
swine
viru
test
mice
induc
protect
immun
infect
heterolog
attenu
strain
equin
herpesviru
alphaherpesviru
infect
hors
impress
safeti
record
hors
mammalian
speci
therefor
consid
attract
vaccin
vector
ha
gene
equin
influenza
viru
clone
could
induc
antibodi
respons
react
multipl
strain
mice
interestingli
protect
efficaci
vaccin
assess
dog
upon
vaccin
partial
protect
infect
canin
influenza
viru
addit
recombin
construct
express
ha
gene
deriv
viru
vaccin
candid
afford
mice
complet
pig
partial
protect
herp
virus
encod
influenza
viru
antigen
mainli
test
candid
vaccin
poultri
protect
effect
confirm
like
dna
virus
herp
virus
rel
larg
genom
antigen
interest
easili
clone
multipl
insert
site
although
advantag
also
complic
character
vector
insert
site
transgen
may
influenc
vesicular
stomat
viru
vsv
rhabdoviru
neg
sens
rna
genom
candid
influenza
vaccin
base
vsv
construct
numer
advantag
vector
vsv
broad
tissu
tropism
easili
deliv
local
contrast
vector
like
adeno
poxvirus
littl
evid
vsv
seroposit
human
elimin
concern
preexist
immun
vector
hand
use
vsv
vector
without
concern
vsv
caus
diseas
known
neuroinvas
current
human
safeti
data
avail
vsvvector
vaccin
addit
experi
requir
overview
vsvbase
influenza
vaccin
found
tabl
vsv
express
ha
gene
influenza
viru
prove
immunogen
mice
protect
anim
challeng
sinc
vsv
also
prove
pathogen
mice
studi
vsv
vector
reli
recombin
attenu
vsv
virus
truncat
defici
g
protein
similar
experi
mice
could
partial
protect
infect
influenza
viru
vaccin
vsv
express
correspond
ha
gene
wherea
express
np
fail
afford
protect
howev
combin
ha
np
construct
result
full
protect
furthermor
vsv
express
ha
gene
influenza
viru
na
gene
influenza
viru
complet
protect
mice
infect
reassort
viru
ha
na
express
ha
gene
viru
afford
chicken
protect
develop
diseas
caus
viru
vsvbase
candid
vaccin
construct
test
chicken
mice
macaqu
immun
vsv
express
ha
gene
differ
avian
virus
complet
protect
chicken
viru
also
mice
macaqu
vsvbase
vaccin
prove
mice
immun
recombin
vsv
express
ha
gene
clade
viru
protect
infect
virus
clade
clade
vsv
also
use
construct
vaccin
aim
induct
broadli
reactiv
hastalk
specif
antibodi
univers
influenza
vaccin
approach
suggest
previous
repeat
vaccin
variou
chimer
ha
molecul
boost
induct
stalkspecif
antibodi
therefor
mice
prime
recombin
vsv
express
ha
gene
stalk
region
influenza
viru
globular
head
domain
viru
subsequ
mice
boost
vsv
express
ha
gene
stalk
head
domain
viru
expect
mice
could
protect
infect
influenza
viru
vaccin
prime
vsv
encod
fulllength
ha
gene
follow
boost
construct
also
afford
protect
infect
viru
interestingli
experi
shown
intranas
primeboost
regimen
perform
better
im
vaccin
newcastl
diseas
viru
ndv
singlestrand
neg
sens
rna
paramyxoviru
caus
diseas
poultri
ndv
sever
favor
properti
vaccin
vector
preexist
immun
human
exist
ndv
easili
attenu
revers
genet
system
rescu
recombin
ndv
place
thu
far
ndv
extens
character
influenza
vaccin
vector
poultri
serv
bival
vaccin
capabl
induc
immun
ndv
influenza
viru
ad
advantag
ndv
easili
administ
poultri
nasal
spray
drink
water
ocular
drop
overview
ndvbase
influenza
vaccin
found
tabl
first
studi
use
ndv
vaccin
vector
influenza
express
ha
gene
influenza
viru
complet
protect
mice
homolog
challeng
infect
achiev
demonstr
ndv
use
influenza
vaccin
consequ
recombin
ndv
express
ha
gene
virus
licens
poultri
vaccin
countri
shown
protect
effect
challeng
infect
virus
chicken
duck
variou
ndv
base
vaccin
offer
partial
crossclad
protect
immunogen
presenc
matern
express
coexpress
na
ndv
improv
immunogen
also
ndv
express
ha
gene
subtyp
test
poultri
although
challeng
virus
lowpathogen
reduct
complet
abrog
viru
shed
could
obtain
inocul
respect
homolog
develop
ndvbase
vaccin
use
human
perform
also
test
mammalian
speci
mice
protect
immun
virus
induc
vaccin
ndv
express
homolog
ha
one
singl
studi
crossreact
cellular
immun
respons
virus
observ
vaccin
immunogen
recombin
ndv
express
ha
na
gene
influenza
viru
test
nonhuman
primat
construct
induc
vn
local
iga
antibodi
respons
afford
protect
challeng
small
number
clinic
trial
perform
ndv
show
vector
well
toler
baculovirus
extens
use
tool
express
produc
influenza
viru
protein
current
recombin
ha
protein
vaccin
produc
baculovirus
approv
human
use
unit
state
howev
baculovirus
also
explor
live
vaccin
vector
sinc
baculovirus
readili
manipul
express
foreign
antigen
infect
mammalian
cell
without
caus
cytopath
effect
potenti
promis
vaccin
vector
influenza
tabl
initi
report
vaccin
recombin
baculoviru
express
ha
gene
influenza
viru
could
induc
complet
protect
homolog
challeng
interestingli
studi
control
group
receiv
empti
baculoviru
express
ha
gene
also
protect
challeng
infect
potenti
induct
strong
nonspecif
innat
immun
respons
vaccin
baculoviru
respons
subsequ
sever
baculovirus
express
ha
gene
variou
influenza
virus
test
mice
afford
protect
infect
homolog
virus
virus
differ
bival
baculoviru
vaccin
express
differ
ha
gene
virus
simultan
also
success
afford
crossclad
final
recombin
baculovirus
express
ha
gene
influenza
virus
capabl
induc
protect
immun
infect
homolog
virus
although
recombin
baculoviru
vector
vaccin
test
mice
efficaci
data
anim
model
still
lack
shortterm
product
baculovirusbas
influenza
viru
vaccin
use
clinic
trial
therefor
like
parainfluenza
viru
like
ndv
neg
sens
rna
paramyxoviru
recent
explor
influenza
viru
vaccin
vector
tabl
favor
properti
vector
includ
broad
tissu
cell
tropism
clinic
diseas
human
avail
revers
genet
system
although
caus
diseas
human
associ
kennel
cough
initi
studi
vaccin
express
ha
viru
afford
protect
homolog
challeng
express
ha
gene
also
complet
protect
mice
infect
homolog
influenza
express
intern
protein
influenza
viru
case
np
gene
construct
could
partial
protect
mice
homolog
challeng
infect
interestingli
express
np
gene
complet
protect
mice
heterolog
challeng
infect
cellular
immun
respons
target
np
respons
correl
similar
result
obtain
recombin
guinea
pig
challeng
homolog
influenza
evalu
mice
guinea
pig
test
candid
influenza
vaccin
anim
model
furthermor
clinic
trial
human
perform
yet
safeti
efficaci
data
therefor
avail
final
littl
known
preexist
immun
vector
human
howev
dog
vector
vaccin
express
ha
gene
influenza
viru
could
still
induc
robust
antibodi
respons
presenc
remain
determin
whether
safe
immunogen
use
human
adenovirus
express
ha
gene
number
differ
subtyp
test
variou
anim
model
first
studi
vaccin
express
ha
gene
influenza
viru
swineorigin
protect
mice
challeng
infect
heterolog
rad
express
ha
gene
differ
viru
shown
efficaci
even
presenc
matern
adenoviru
vaccin
express
ha
gene
complet
protect
mice
homolog
challeng
pig
could
also
protect
viru
infect
vaccin
express
ha
gene
viru
interestingli
pig
also
partial
protect
vaccin
construct
infect
heterolog
rad
express
ha
gene
protect
mice
chicken
ferret
infect
homolog
ha
gene
introduc
rad
crossclad
protect
rad
express
ha
gene
viru
immunogen
chicken
capabl
protect
chicken
homolog
challeng
comprehens
studi
test
vector
express
ha
gene
avian
virus
subtyp
combin
thereof
show
mice
could
protect
homolog
challeng
infect
heterosubtyp
immunit
never
observ
howev
shown
simultan
vaccin
differ
vaccin
feasibl
protect
challeng
infect
virus
subtyp
compar
express
modifi
influenza
antigen
vector
goal
induc
univers
influenza
immun
ie
headless
ha
chimer
ha
consensu
sequenc
rad
express
modifi
ha
gene
construct
ha
gene
modifi
shield
immunodomin
head
region
glycan
redirect
immun
respons
ha
head
region
target
conserv
stalk
region
afford
broad
protect
inde
rad
express
ha
gene
influenza
viru
either
wildtyp
glycosyl
afford
crossclad
protect
mice
glycosyl
ha
perform
better
wildtyp
heterosubtyp
immun
glycanshield
construct
report
yet
differ
vaccin
regimen
rad
construct
express
np
gene
test
anim
model
report
heterosubtyp
immun
express
np
gene
could
partial
protect
mice
infect
influenza
virus
vice
versa
rad
express
np
gene
avian
viru
complet
protect
mice
infect
howev
vaccin
pig
compar
construct
could
afford
protect
homolog
challeng
infect
wherea
addit
construct
vaccin
cocktail
complet
restor
protect
vaccin
mice
combin
vaccin
includ
construct
express
np
gene
protect
mice
homolog
challeng
express
consensu
sequenc
could
even
afford
protect
infect
variou
influenza
abrog
contact
transmiss
sentinel
np
consensu
gene
sequenc
express
rad
vaccin
led
partial
immun
viru
infect
mice
similar
rad
vaccin
express
np
gene
viru
induc
tcell
respons
prove
safe
recent
novel
approach
test
construct
express
mirna
target
np
rna
influenza
viru
construct
protect
mice
challeng
bival
vaccin
express
ha
na
consensu
gene
sequenc
multipl
virus
protect
mice
ferret
infect
influenza
trival
vaccin
express
gene
addit
ha
na
gene
either
pandem
avian
influenza
protect
mice
challeng
infect
virus
differ
clade
take
one
step
pentaval
vaccin
express
ha
na
gene
avian
ha
na
gene
pandem
perform
superior
induc
protect
recombin
extens
test
heterolog
prime
boost
vaccin
regimen
anim
prime
dna
encod
ha
np
andor
gene
subsequ
boost
express
protein
dna
prime
follow
boost
vaccin
complet
protect
mice
homolog
challeng
infect
afford
heterosubtyp
immun
upon
infect
influenza
contrari
ferret
could
protect
infect
vaccin
similar
neg
result
obtain
ferret
rad
construct
express
heterolog
prime
boost
regimen
dna
vaccin
follow
vaccin
bival
construct
express
np
gene
mice
complet
protect
infect
conflict
result
obtain
recombin
express
ha
gene
alway
protect
ferret
dna
prime
follow
boost
regimen
use
induc
protect
infect
homolog
viru
adenoassoci
viru
aav
parvoviru
replicationdefici
human
like
adenoviru
aav
broad
cell
tissu
host
tropism
therefor
potenti
good
vector
howev
drawback
use
aav
includ
limit
capac
transgen
presenc
preexist
immun
human
technic
challeng
produc
high
titer
stock
initi
aav
explor
vaccin
vector
consid
poorli
immunogen
howev
vaccin
studi
mice
show
express
glycoprotein
immunogen
potent
induc
tcell
antibodi
current
modif
made
aav
increas
limit
number
studi
evalu
aav
vector
influenza
vaccin
perform
tabl
initi
aav
express
ha
gene
np
gene
shown
protect
recent
studi
test
aav
vaccin
express
ha
np
gene
mice
wherea
aavha
afford
full
protect
infect
aavnp
protect
mice
partial
afford
protect
simultan
vaccin
construct
afford
protect
homolog
challeng
recent
altern
vaccin
approach
aav
construct
express
transgen
encod
influenza
virusspecif
broadli
neutral
antibodi
aav
construct
express
broadli
neutral
antibodi
protect
mice
infect
differ
wherea
aav
express
broadli
neutral
antibodi
protect
mice
ferret
infect
variou
viral
vector
potenti
novel
vaccin
candid
time
press
need
gamechang
vaccin
induc
broadli
protect
immun
wide
varieti
influenza
virus
major
advantag
viral
vector
possibl
express
foreign
antigen
without
modif
vivo
sinc
protein
express
nativ
confirm
antibodi
respons
desir
specif
induc
addit
viral
vector
allow
de
novo
protein
synthesi
cytoplasm
infect
cell
facilit
endogen
antigen
process
mhc
class
present
immunogen
peptid
requir
effici
induct
virusspecif
tcell
respons
although
vector
discuss
respect
advantag
disadvantag
replicationdefici
mammalian
host
cell
therefor
safe
human
use
even
immunocompromis
individu
preexist
immun
vector
may
pose
problem
vector
howev
viral
vector
avail
like
vsv
human
popul
immunolog
vector
like
mva
prove
immunogen
even
presenc
preexist
immun
vector
technolog
safeti
concern
like
use
herp
virus
persist
infect
host
dna
vaccin
might
integr
host
genom
properti
might
restrict
applic
prophylact
vaccin
discuss
review
viral
vector
potenti
influenza
vaccin
candid
evalu
anim
model
human
also
extens
test
influenza
viru
reservoir
speci
vaccin
reservoir
speci
could
potenti
limit
transmiss
avian
swine
influenza
viru
transmiss
therefor
limit
zoonot
transmiss
potenti
pre
pandem
virus
human
host
futur
novel
vectorbas
influenza
candid
vaccin
develop
test
clinic
trial
potenti
improv
modif
viral
antigen
like
headless
shield
ha
construct
broaden
reactiv
vaccin
induc
antibodi
addit
modifi
influenza
viru
antigen
posttransl
modif
modif
promot
sequenc
could
also
alter
improv
biggest
challeng
take
vectorbas
vaccin
market
may
obtain
approv
regulatori
author
safeti
superior
exist
vaccin
formul
demonstr
implement
novel
vectorbas
vaccin
may
consid
